BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22032474)

  • 1. Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.
    Papp K; Poulin Y; Barber K; Lynde C; Prinz JC; Berg M; Kerrouche N; Rives VP
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1407-14. PubMed ID: 22032474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
    Sofen H; Hudson CP; Cook-Bolden FE; Preston N; Colón LE; Colón LE; Caveney SW; Gottschalk RW
    J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
    Poulin Y; Papp K; Bissonnette R; Barber K; Kerrouche N; Villemagne H;
    J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
    Poulin Y; Papp K; Bissonnette R; Guenther L; Tan J; Lynde C; Kerrouche N; Villemagne H;
    Cutis; 2010 Jan; 85(1):43-50. PubMed ID: 20184211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.
    Bovenschen HJ; Van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
    Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
    J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
    Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
    J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
    Brodell R; Preston N
    J Drugs Dermatol; 2012 Dec; 11(12):1455-9. PubMed ID: 23377516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
    Reygagne P; Poncet M; Sidou F; Soto P
    Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
    Mazzotta A; Esposito M; Carboni I; Schipani C; Chimenti S
    J Dermatolog Treat; 2007; 18(2):84-7. PubMed ID: 17520464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and scalp psoriasis.
    Koo J
    Cutis; 2002 Nov; 70(5 Suppl):21-4. PubMed ID: 12467336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.
    Tan J; Thomas R; Wang B; Gratton D; Vender R; Kerrouche N; Villemagne H;
    Cutis; 2009 Mar; 83(3):157-64. PubMed ID: 19363909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K; Chakrabarty A; Lemke S; Yu K
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of therapeutic shampoos for targeting symptoms of inflammatory scalp disorders.
    Kircik L
    J Drugs Dermatol; 2010 Jan; 9(1):41-8. PubMed ID: 20120424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers.
    Aubert J; Reiniche P; Fogel P; Poulin Y; Lui H; Lynde C; Shapiro J; Villemagne H; Soto P; Voegel JJ
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1304-11. PubMed ID: 20337827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalp psoriasis.
    Kircik LH; Kumar S
    J Drugs Dermatol; 2010 Aug; 9(8 Suppl ODAC Conf Pt 2):s101-5. PubMed ID: 20715392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.